Lukas Scheibler

(Dr. Lukas Scheibler Ph.D.)

Currently holds a position at Apellis Pharmaceuticals Inc

Positions

Position Company Period
Chief Innovation Officer Apellis Pharmaceuticals Inc April 1, 2019 -
Executive Vice President - Research and Development Apellis Pharmaceuticals Inc April 1, 2018 - April 1, 2019
Lukas Scheibler's trades of Apellis Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-12-05 2023-12-01 PS Planned sale
10,000 -12.8%
60.00
USD 600,000
10,000 -12.8% 60.00 USD 600,000
2023-09-07 2023-09-06 S Sale
1,756 -2.5%
43.01
USD 75,526
1,756 -2.5% 43.01 USD 75,526
2022-05-31 2022-05-27 PS Planned sale
10,000 -19.9%
43.00
USD 430,000
10,000 -19.9% 43.00 USD 430,000
2022-04-06 2022-04-05 PS Planned sale
609 -1.2%
60.09
USD 36,593
609 -1.2% 60.09 USD 36,593
2022-04-05 2022-04-04 PS Planned sale
1,249 -2.3%
57.81
USD 72,198
1,249 -2.3% 57.81 USD 72,198
2022-04-05 2022-04-04 PS Planned sale
1,437 -2.6%
56.86
USD 81,714
1,437 -2.6% 56.86 USD 81,714
2022-04-05 2022-04-04 PS Planned sale
818 -1.5%
55.84
USD 45,677
818 -1.5% 55.84 USD 45,677
2022-04-04 2022-04-01 PS Planned sale
11,496 -18.0%
55.05
USD 632,855
11,496 -18.0% 55.05 USD 632,855
2022-02-14 2022-02-11 PS Planned sale
1,666 -3.1%
46.80
USD 77,969
1,666 -3.1% 46.80 USD 77,969
2022-02-14 2022-02-10 PS Planned sale
10,000 -15.8%
50.00
USD 500,000
10,000 -15.8% 50.00 USD 500,000
2022-02-10 2022-02-08 PS Planned sale
10,000 -15.7%
45.00
USD 450,000
10,000 -15.7% 45.00 USD 450,000
2022-02-01 2022-01-31 PS Planned sale
1,233 -2.2%
38.47
USD 47,434
1,233 -2.2% 38.47 USD 47,434
2021-06-11 2021-06-10 PS Planned sale
3,417 -11.4%
60.00
USD 205,020
3,417 -11.4% 60.00 USD 205,020
// ... existing code ... // ... rest of the file ...